rs587777179
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006767.4(LZTR1):c.2348_2351delCGCA(p.Thr783ArgfsTer5) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,612,410 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006767.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LZTR1 | NM_006767.4 | c.2348_2351delCGCA | p.Thr783ArgfsTer5 | frameshift_variant | Exon 20 of 21 | ENST00000646124.2 | NP_006758.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460180Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726176
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
LZTR1-related schwannomatosis Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Thr783Argfs*5) in the LZTR1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 58 amino acid(s) of the LZTR1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of schwannomatosis (PMID: 24362817). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 101037). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the LZTR1 protein in which other variant(s) (p.Ile821Thr, p.Cys792Gly, p.Asp819His) have been observed in individuals with LZTR1-related conditions (PMID: 29469822, 30732632, 31219622). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The c.2348_2351delCGCA variant, located in coding exon 20 of the LZTR1 gene, results from a deletion of 4 nucleotides at nucleotide positions 2348 to 2351, causing a translational frameshift with a predicted alternate stop codon (p.T783Rfs*5). This alteration occurs at the 3' terminus of the LZTR1 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 58 amino acids of the protein. However, premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). This variant has been identified in one individual with schwannomatosis and segregated with disease in two affected family members; analysis of a schwannoma was also consistent with the known mechanism of tumorigenesis (Piotrowski A et al. Nat Genet, 2014 Feb;46:182-7). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is likely pathogenic for an increased risk of LZTR1-related schwannomatosis (SWN) and would be expected to cause autosomal recessive Noonan syndrome when present along with a second pathogenic or likely pathogenic variant on the other allele; however, the association of this alteration with autosomal dominant Noonan syndrome is unlikely. -
Noonan syndrome 2 Pathogenic:1
This sequence variant is a deletion of 4 nucleotides (delCGCA) from coding nucleotide positions 2348 through 2351 in the LZTR1 gene which results in an early termition codon 5 positions downstream of the frameshift introduced at codon 783. As it occurs in exon 20 of 21, this variant is predicted to generate a non-functiol allele through either the expression of a truncated protein or a loss of LZTR1 expression due to nonsense-mediated decay. This is a previously reported variant (ClinVar) which has been observed in the literature in multiple family members with schwannomatosis (PMID: 24362817). This variant is absent from the gnomAD control population dataset (0/~250000 alleles). Based on the available evidence, we consider this variant to be pathogenic. ACMG Criteria: PM2, PP1, PVS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at